Anthony Buonanno, MD
Orthopaedic Surgery · Johnston, RINPI 1831157759
Payments from drug & device makers
What this record shows
This record is dominated by ownership interests: $1,678,961 of the $1,988,927 with a category attached, or 84.4%. Anika Therapeutics, Inc. accounts for 98.2% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2020 at $1,681,296 and has fallen 99.8% since, to $3,400 in 2025. Among orthopaedic surgery clinicians in RI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 14 payments — averaging $142,066 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Anika Therapeutics, Inc.$2M
- Primo Medical Group, Inc. (f.k.a. STD Med Inc.)$36K
- Spirus Medical LLC$139
- Stryker$79
- Genentech USA, Inc.$14
- Cardiosolutions, Inc.$0
What the payments were for
- Consulting fees$32,5272%
- Speaking & faculty fees$3,0000%
- Food & beverage$2310%
- Ownership interest$1,678,96184%
- Other$274,20714%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Anika Therapeutics, Inc. | 4 | $1,953,168 |
| Primo Medical Group, Inc. (f.k.a. STD Med Inc.) | 6 | $35,527 |
| Spirus Medical LLC | 1 | $139 |
| Stryker | 1 | $79 |
| Genentech USA, Inc. | 1 | $14 |
| Cardiosolutions, Inc. | 1 | $0 |
How this compares
$1,988,927 in reported general payments places this provider in the 95th percentile of 124 orthopaedic surgery providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 36 | $1,746 |
| Ibuprofen | 212 | $1,479 |
| Methylprednisolone | 14 | $113 |
| IbuIbuprofen | 13 | $81 |
| Meloxicam | 34 | $73 |
| Naproxen | 11 | $52 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Johnston
- Michel ArcandJohnston$46K
- Alan DanielsEast Providence$1.9M
- Robert MarchandWakefield$1.4M
- Michael BradleyWakefield$1.4M
- Edward PaxtonProvidence$244K
- Valentin AntociEast Providence$210K
- Dominic KleinhenzEast Providence$164K
- Bassel DieboEast Providence$138K
- Steven BokshanProvidence$130K
- Ian MadomWakefield$125K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.